Crossmark

Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)

Crossref DOI link: https://doi.org/10.1016/j.rpsmen.2021.08.002

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Son J., Mayoral-van

Gómez-Revuelta, Marcos

Ayesa-Arriola, Rosa

Vázquez-Bourgón, Javier

Foz, Víctor Ortiz-García de la

Ruiz-Veguilla, Miguel

Garrido, Nathalia

Tordesillas-Gutiérrez, Diana

Setién-Suero, Esther

Crespo-Facorro, Benedicto
License Information

Text and Data Mining valid from 2021-07-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)

Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2021.08.002

Content Type: article

Copyright: © 2021 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below